DOXIMITY INC-CLASS A (DOCS) Stock Analyst Ratings
USA - NYSE:DOCS - US26622P1075 - Common Stock
54.29 USD
-8.29 (-13.25%)
54.4999 USD
+0.21 (+0.39%)
ChartMill assigns a Buy % Consensus number of 77% to DOCS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 72.99. This target is 34.44% above the current price.
DOCS was analyzed by 26 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about DOCS.
In the previous month the buy percentage consensus was at a similar level.
DOCS was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-27 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-10-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-01 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-09-18 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-09-11 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-08 | Needham | Maintains | Buy -> Buy |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-08-08 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-17 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-09 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2025-06-25 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-06-02 | BTIG | Upgrade | Neutral -> Buy |
| 2025-05-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-05-21 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-20 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-16 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-05-16 | Needham | Maintains | Buy -> Buy |
| 2025-05-16 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-05-16 | Truist Securities | Maintains | Hold -> Hold |
| 2025-05-16 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-16 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-10 | Truist Securities | Maintains | Hold -> Hold |
DOXIMITY INC-CLASS A / DOCS FAQ
What is the price target for DOCS stock?
26 analysts have analysed DOCS and the average price target is 72.99 USD. This implies a price increase of 34.44% is expected in the next year compared to the current price of 54.29.
How do analysts rate DOXIMITY INC-CLASS A (DOCS)?
The consensus rating for DOXIMITY INC-CLASS A (DOCS) is 76.9231 / 100 . This indicates that analysts generally have a positive outlook on the stock.